NCT00005877View on ClinicalTrials.gov

Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

September 30, 1999

Conditions
Colorectal Cancer
Interventions
DRUG

rubitecan

Trial Locations (1)

94568

SuperGen, Incorporated, Dublin

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY